Quantcast
Channel: Technologies related to Biodefense
Viewing all articles
Browse latest Browse all 75

Monoclonal Antibodies Against Coxiella burnetii, the Cause of Q Fever for Diagnostic Development

$
0
0

Coxiella burnetii (C. burnetii), the bacterium that causes Q fever, gets transmitted by inhalation and remains extremely stable in the environment. It has a very low infectious dose (very few bacteria can cause illness), making it a potential agent for bioterrorism. These factors have led to inclusion of C. burnetii on the Health and Human Services list of Select Agents. Cattle, sheep, and goats commonly get infected with C. burnetii. People, especially those who handle farm animals, can become exposed to C. burnetii by breathing in dust contaminated from infected animal body fluids.

Inventor First Name: 
Gilbert
Inventor Last Name: 
Kersh
E Number Only: 
E-194-2016
Inv Is lead: 
Provider Technology ID: 
3432
LPM Zip: 
20892-9804
LPM Organization: 
NIH Office of Technology Transfer
LPM Phone: 
301-443-8518
LPM State: 
MD
  • Antibody
  • Platform
Updated On: 
Friday, February 19, 2021
Related Invention: 
E-207-2020-0
LPM Last Name: 
Mitzelfelt
LPM FIrst Name: 
Jeremiah
Date Published: 
Friday, February 19, 2021
DTDT Classification: 
Biodefense Related
Infectious Diseases (bacterial)
Zoonotic/Veterinary
Biodefense
Diagnostic
Monitoring (Public Health/Counterfeit Detection/Biological)
Quality Control/Quality Assurance
Research Tool
Other (this will include others such as manufacturing, consumer products and vet
Antibody
Platform
In vitro data available
In vivo data available (animal)
DTDT Description: 
Biodefense Related
Infectious Diseases (bacterial)
Zoonotic/Veterinary
Biodefense
Diagnostic
Monitoring (Public Health/Counterfeit Detection/Biological)
Quality Control/Quality Assurance
Research Tool
Other (this will include others such as manufacturing, consumer products and vet
Antibody
Platform
In vitro data available
In vivo data available (animal)
Collaboration Sought: 
Yes
Collaboration Opportunity: 

The CDC Technology Transfer Office (TTO) seeks statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize: Monoclonal Antibodies Against Coxiella burnetii, the Cause of Q Fever for Diagnostic Development. For collaboration opportunities, please contact CDC TTO at tto@cdc.gov or 1-404-639-1330.

Advantages: 
  • Antibodies allow definitive detection and differentiation of different phase variants of the bacterium
  • Potential for use in antibody arrays as a rapid screen for surveillance of pathogens or outbreak investigations
  • Currently, there are no antibodies specific for C. burnetii available for purchase in the U.S. market
Applications: 
  • Diagnostic tests to confirm C. burnetii in human and veterinary samples
  • Immunohistochemistry assays
  • Companion diagnostic
  • Biodefense
  • Public health monitoring, surveillance, and outbreak investigations
  • Quality control in clinical and diagnostic tests for Q fever
  • Research tools
NIH Ref. No.: 
E-194-2016-0
IC: 
CDC
LPM Address: 
BG 5601FL RM 2G29 MSC 9804 5601 FISHERS LN
LPM City: 
Bethesda
Inventor IC: 
CDC
Institute or Center: 
Lead Inventor: 

Viewing all articles
Browse latest Browse all 75

Latest Images

Trending Articles





Latest Images